Asset Details
Do you wish to reserve the book?
Acute kidney injury in COVID-19 pediatric patients in North America: Analysis of the virtual pediatric systems data
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Acute kidney injury in COVID-19 pediatric patients in North America: Analysis of the virtual pediatric systems data
Do you wish to request the book?
Acute kidney injury in COVID-19 pediatric patients in North America: Analysis of the virtual pediatric systems data
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Acute kidney injury in COVID-19 pediatric patients in North America: Analysis of the virtual pediatric systems data
2022
Overview
Despite extensive research into acute kidney injury (AKI) in adults, research into the epidemiology, associated risk factors, treatment, and mortality of AKI in pediatric COVID-19 patients is understudied. Advancing understanding of this disease is crucial to further developing treatment and preventative care strategies to reduce morbidity and mortality.
This is a retrospective analysis of 2,546 COVID-19 pediatric patients (age ≤ 21 years) who were admitted the ICU in North America. Analysis of the Virtual Pediatric Systems (VPS) COVID-19 database was conducted between January 1, 2020, and June 30, 2021.
Out of a total of 2,546 COVID positive pediatric patients, 10.8% (n = 274) were diagnosed with AKI. Significantly higher continuous and categorical outcomes in the AKI subset compared to the non-AKI cohort included: length of stay at the hospital (LOS) [9.04 (5.11-16.66) vs. 5.09 (2.58-9.94) days], Pediatric Index of Mortality (PIM) 2 probability of death [1.20 (0.86-3.83) vs. 0.96 (0.79-1.72)], PIM 3 probability of death [0.98 (0.72-2.93) vs. 0.78 (0.69-1.26)], mortality [crude OR (95% CI): 5.01 (2.89-8.70)], airway and respiratory support [1.63 (1.27-2.10)], cardio-respiratory support [3.57 (1.55-8.23)], kidney support [12.52 (5.30-29.58)], and vascular access [4.84 (3.70-6.32)].
This is one of the first large scale studies to analyze AKI among pediatric COVID-19 patients admitted to the ICU in North America. Although the course of the COVID-19 virus appears milder in the pediatric population, renal complications may result, increasing the risk of disease complication and mortality.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
Acute Kidney Injury - epidemiology
/ Acute Kidney Injury - etiology
/ Acute Kidney Injury - therapy
/ Acute renal failure in children
/ Adult
/ Age
/ Child
/ Children
/ COVID-19
/ Diseases
/ Female
/ Humans
/ Kidneys
/ Male
/ Medicine and Health Sciences
/ Ostomy
/ Patients
/ Severe acute respiratory syndrome coronavirus 2
/ Software
/ Viruses
